Long Noncoding RNA CCAT1 Promotes Hepatocellular Carcinoma Progression by Functioning As Let-7 Sponge

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2015 Apr 18

PMID 25884472

Citations 168

Authors

Liang Deng

Shi-Bin Yang

Feng-Feng Xu

Ji-Hong Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Long noncoding RNAs (lncRNAs) have been identified as having functional roles in cancer biology and are deregulated in many cancers. The present study aimed to determine the expression, roles and functional mechanisms of a long noncoding RNA CCAT1 in the progression of hepatocellular carcinoma (HCC).

Methods: CCAT1 expression levels in 66 pairs of HCC tissues and pair-matched noncancerous hepatic tissues were tested by real-time PCR. The effects of CCAT1 on HCC cells proliferation and migration were assessed using in vitro cell proliferation and migration assays. A computational screen of microRNAs (miRNAs) target sites in CCAT1 was conducted to search for specific miRNAs binding to CCAT1. The specific binding between CCAT1 and miRNAs was confirmed by RNA immunoprecipitation assay combined with luciferase reporter assay.

Results: CCAT1 levels are markedly increased in HCC tissues compared with pair-matched noncancerous hepatic tissues. Up-regulation of CCAT1 is correlated with tumor size, microvascular invasion, AFP and poor prognosis. CCAT1 promotes the proliferation and migration of HCC cells. CCAT1 functions as a molecular sponge for let-7, antagonizes its functions, and leads to the de-repression of its endogenous targets HMGA2 and c-Myc. The effect of CCAT1 on HCC cell proliferation and migration is dependent upon its competitively binding to let-7.

Conclusions: These data suggest that CCAT1 plays a pivotal role in HCC progression via functioning as let-7 sponge, and implicate the potential application of CCAT1 for the prognosis and treatment of HCC.

Citing Articles

FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.

Guo S, Huang B, You Z, Luo Z, Xu D, Zhang J BMC Oral Health. 2024; 24(1):625.

PMID: 38807101 PMC: 11134640. DOI: 10.1186/s12903-024-04388-2.

Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis.

Huang S, Liao Z, He X, Song Z, Fang X, Wen S BMC Cancer. 2024; 24(1):550.

PMID: 38693503 PMC: 11064308. DOI: 10.1186/s12885-024-12309-3.

The role of long non-coding RNA in hepatocellular carcinoma.

Liang W, Zhao Y, Meng Q, Jiang W, Deng S, Xue J Aging (Albany NY). 2024; 16(4):4052-4073.

PMID: 38334963 PMC: 10929815. DOI: 10.18632/aging.205523.

Functionalized Carbon Nanotubes for Delivery of Ferulic Acid and Diosgenin Anticancer Natural Agents.

AbouAitah K, Abdelaziz A, Higazy I, Swiderska-Sroda A, Hassan A, Shaker O ACS Appl Bio Mater. 2024; 7(2):791-811.

PMID: 38253026 PMC: 10880110. DOI: 10.1021/acsabm.3c00700.

Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes.

Franz C, Wuehrl M, Hartmann S, Klupp F, Schmidt T, Schneider M PLoS One. 2023; 18(6):e0286486.

PMID: 37347737 PMC: 10287004. DOI: 10.1371/journal.pone.0286486.

References

Yang L, Froberg J, Lee J . Long noncoding RNAs: fresh perspectives into the RNA world. Trends Biochem Sci. 2013; 39(1):35-43. PMC: 3904784. DOI: 10.1016/j.tibs.2013.10.002. View

Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet J . Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis. 2010; 30(1):35-51. PMC: 3668687. DOI: 10.1055/s-0030-1247131. View

Chen K, Hou Y, Wang K, Li J, Xia Y, Yang X . Reexpression of Let-7g microRNA inhibits the proliferation and migration via K-Ras/HMGA2/snail axis in hepatocellular carcinoma. Biomed Res Int. 2014; 2014:742417. PMC: 3960551. DOI: 10.1155/2014/742417. View

Karreth F, Tay Y, Perna D, Ala U, Tan S, Rust A . In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell. 2011; 147(2):382-95. PMC: 3236086. DOI: 10.1016/j.cell.2011.09.032. View

Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, Halle D, Grinbaum R, Roistacher M . Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues. Int J Cancer. 2011; 130(7):1598-606. DOI: 10.1002/ijc.26170. View

Forner A, Llovet J, Bruix J . Hepatocellular carcinoma. Lancet. 2012; 379(9822):1245-55. DOI: 10.1016/S0140-6736(11)61347-0. View

Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y . Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol. 2012; 139(3):437-45. DOI: 10.1007/s00432-012-1324-x. View

Batista P, Chang H . Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013; 152(6):1298-307. PMC: 3651923. DOI: 10.1016/j.cell.2013.02.012. View

Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L . Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013; 25(1):69-80. DOI: 10.1016/j.devcel.2013.03.002. View

10.

Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X . Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest. 2013; 123(2):630-45. PMC: 3561812. DOI: 10.1172/JCI64265. View

11.

Wang Y, Dong Y, Wang W, Xie X, Wang Z, Chen R . Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines. J Exp Clin Cancer Res. 2013; 32(1):51. PMC: 3751285. DOI: 10.1186/1756-9966-32-51. View

12.

Kallen A, Zhou X, Xu J, Qiao C, Ma J, Yan L . The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013; 52(1):101-12. PMC: 3843377. DOI: 10.1016/j.molcel.2013.08.027. View

13.

Li L, Sun R, Liang Y, Pan X, Li Z, Bai P . Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer. J Exp Clin Cancer Res. 2013; 32:104. PMC: 4029281. DOI: 10.1186/1756-9966-32-104. View

14.

Yuan J, Yang F, Wang F, Ma J, Guo Y, Tao Q . A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25(5):666-81. DOI: 10.1016/j.ccr.2014.03.010. View

15.

Zhou B, Chen H, Wei D, Kuang Y, Zhao X, Li G . A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2014; 33:55. PMC: 4096530. DOI: 10.1186/1756-9966-33-55. View

16.

Fan M, Huang C, Gu Y, Xiao Y, Sheng J, Zhong L . Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. J Exp Clin Cancer Res. 2013; 32(1):21. PMC: 3699415. DOI: 10.1186/1756-9966-32-21. View

17.

Zhou S, Wang J, Zhang Z . An emerging understanding of long noncoding RNAs in kidney cancer. J Cancer Res Clin Oncol. 2014; 140(12):1989-95. DOI: 10.1007/s00432-014-1699-y. View

18.

Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

19.

Meng J, Li P, Zhang Q, Yang Z, Fu S . A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res. 2014; 33:84. PMC: 4198622. DOI: 10.1186/s13046-014-0084-7. View

20.

Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A . The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol. 2010; 52(5):698-704. DOI: 10.1016/j.jhep.2009.12.024. View